QC
QUAKER CHEMICAL CORP (KWR)·Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 net sales were $444.1M, GAAP diluted EPS $0.81, and non-GAAP diluted EPS $1.33; adjusted EBITDA was $64.8M as softer end markets, mix, FX and manufacturing absorption weighed on margins (gross margin 35.2%) .
- Versus Q3 2024, sales fell ~4% and adjusted EBITDA declined to $64.8M from $78.6M; versus Q4 2023, sales -4.9%, adjusted EBITDA -15.9%, and non-GAAP EPS -25.5% .
- Management expects FY2025 revenue, adjusted EBITDA and EPS growth; gross margins comparable to 2024; incremental cost actions of $20M run-rate (~$15M in-year) and tax rate ~29%; capex planned at 2.5–3.5% of sales due to China plant and Philadelphia consolidation .
- Liquidity remains solid: gross debt $708.3M, cash $188.9M, net debt $519.4M, leverage 1.7x; Q4 operating cash flow of ~$63M and FY2024 OCF $204.6M; dividend declared at $0.485/share (April 30, 2025) .
- Potential stock catalysts: confirmation of sequential margin recovery in Q1 (management expects Q1 to be the lowest quarter with improvement through Q2/Q3), execution on Asia-Pacific share gains and FLUID INTELLIGENCE initiatives, and delivery of cost savings; FX is expected to be a low-single-digit sales headwind .
What Went Well and What Went Wrong
What Went Well
- Asia/Pacific net sales grew 5% YoY on volume gains and acquisition contribution; segment operating earnings remained resilient with margins consistent vs 2023 despite raw material cost headwinds .
- New business wins across all regions supported stable volumes despite declines in aggregate end markets; management highlighted targeted 2–4% net new wins globally and early traction in advanced/operating solutions .
- Strong cash generation and disciplined capital allocation: FY2024 operating cash flow $204.6M; ~$82.4M returned to shareholders via dividends and buybacks with $101M remaining authorization .
What Went Wrong
- Americas and EMEA saw broad-based production weakness, lower aerospace sales, and unfavorable mix; Americas net sales -8% YoY and segment earnings -$11M YoY; EMEA net sales -7% YoY and segment earnings -$5M YoY .
- Gross margin compressed to 35.2% in Q4 due to manufacturing absorption, higher raw material costs in APAC/EMEA, and mix (lower service revenues); adjusted EBITDA margin declined to 14.6% vs 16.5% in Q4 2023 .
- FX was a 2% sales headwind in Q4 and is expected to be a low-single-digit headwind in 2025; selling price/product mix declined ~4% QoQ and YoY due to index-based contracts and mix of products/services .
Financial Results
Core metrics vs prior year and prior quarter
Segment breakdown
KPIs and Liquidity
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We expect to deliver revenue, adjusted EBITDA and earnings growth in 2025… taking additional steps to reduce complexity which are expected to deliver run-rate cost savings of at least $20 million in 2025.” — Joseph Berquist, CEO .
- “Gross margins were 35.2% in the fourth quarter… impacted by manufacturing absorption, timing of raw material cost increases and mix… these latter issues have largely resolved themselves in January.” — Joseph Berquist .
- “Our effective tax rate… was approximately 34% in the fourth quarter or 29% for the full year. We expect… 2025 will be approximately 29%.” — Tom Coler, CFO .
- “We are aligning our resources with faster growing regions… excited by the momentum in our advanced and operating portfolio… will simplify and refocus the organization on value-enhancing activities.” — Joseph Berquist .
Q&A Highlights
- Gross margin target: Management reaffirmed long-term gross margin “zip code” of 37–38%; expects Q1 margins to recover toward last year’s range and ultimately drive EBITDA margins toward high-teens to ~20% over time .
- Regional performance: APAC success driven by share gains in metals and EV supply chain; strategy to translate wins to Americas/EMEA via equipment-supported first-fill and customer intimacy model .
- 2025 outlook: Markets expected to grow ~1–2% with easier comps after H2’24 trough; FX a low single-digit sales headwind; raw materials stable; sequential improvement through the year .
- Cost and SG&A: $20M run-rate cost actions with ~$15M in-year savings; SG&A expected flat to modestly up in 2025 amid compensation rebuild and targeted investments; focus on EMEA manufacturing optimization .
- Capex and capital allocation: Capex 2.5–3.5% of sales for 2025 (China plant, Philadelphia consolidation); priority on M&A to enhance scale in emerging geographies; opportunistic buybacks remain a lever ($101M authorization) .
Estimates Context
- Wall Street consensus (S&P Global) for Q4 2024 EPS and revenue was unavailable due to data access limits during this session; therefore, we cannot provide a beat/miss assessment vs consensus at this time [SPGI retrieval error encountered].
- Given the absence of consensus figures, investors should anchor on company-reported metrics and management outlook until estimates are refreshed .
Consensus vs Actual (informational)
Key Takeaways for Investors
- Near-term: Q1 expected to be the lowest quarter, with sequential margin and demand improvement through Q2/Q3; watch for gross margin recovery toward the 37–38% “zip code” and adj EBITDA uptick from Q4 levels .
- Cost program: $20M run-rate cost actions (~$15M in-year) are a tangible EPS lever for 2025; monitor SG&A trajectory and EMEA network optimization progress .
- APAC-led growth: Asia/Pacific volume gains and Sutai integration demonstrate share capture; track pipeline conversion in India/SE Asia and spillover to Americas/EMEA via first-fill/service offerings .
- Mix and price dynamics: Index-linked contracts and lower service revenue pressured Q4 price/mix; stabilization plus higher production rates should support margin normalization in 2025 .
- FX risk: Low-single-digit sales headwind expected; portfolio/geographic diversification helps, but hedging/price actions will be important if volatility persists .
- Balance sheet and cash returns: Leverage at 1.7x TTM adj EBITDA with strong OCF; dividend maintained at $0.485/share and remaining buyback authorization of $101M offers flexibility .
- Strategic narrative: New CEO is refocusing on customer intimacy and FLUID INTELLIGENCE; execution against growth in advanced/operating solutions can be a medium-term multiple driver .
Appendix: Non-GAAP Adjustments (Q4 2024)
- Key reconciling items included executive transition costs ($6.6M), restructuring ($1.7M), customer insolvency ($1.7M), product liability costs ($1.1M), and currency impacts; non-GAAP operating margin 9.1% and non-GAAP EPS $1.33 .